Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...

B uying stocks for the long term is a smart financial move. It allows an investor to benefit from the growth of a business and from the growth of the overall economy over time. Th ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...